MicroRNAs and prostate cancer

Valeria Coppola; Ruggero De Maria; Désirée Bonci

doi:10.1677/ERC-09-0172

MicroRNAs and prostate cancer

Valeria Coppola, Ruggero De Maria, Désirée Bonci

Istituto Regina Elena

Research output: Contribution to journal › Article › peer-review

Abstract

Despite much progress in prostate cancer management, new diagnostic, prognostic and therapeutic tools are needed to predict disease severity, choose among the available treatments and establish more effective therapies for advanced prostate cancer. In the last few years, compelling evidence has documented the role of microRNAs as new broad-spectrum oncogenes or tumour suppressor genes, thus their use as diagnostic, prognostic and therapeutic biomolecules is envisaged. This review extensively and critically summarizes the current knowledge about microRNAderegulation in prostate cancer disease, underlining present limits and future perspectives.

Original language	English
Journal	Endocrine-Related Cancer
Volume	17
Issue number	1
DOIs	https://doi.org/10.1677/ERC-09-0172
Publication status	Published - Mar 2010

ASJC Scopus subject areas

Cancer Research
Endocrinology
Endocrinology, Diabetes and Metabolism
Oncology

Access to Document

10.1677/ERC-09-0172

Cite this

@article{b0caf93dbe794f1f915394931cd17fd4,

title = "MicroRNAs and prostate cancer",

abstract = "Despite much progress in prostate cancer management, new diagnostic, prognostic and therapeutic tools are needed to predict disease severity, choose among the available treatments and establish more effective therapies for advanced prostate cancer. In the last few years, compelling evidence has documented the role of microRNAs as new broad-spectrum oncogenes or tumour suppressor genes, thus their use as diagnostic, prognostic and therapeutic biomolecules is envisaged. This review extensively and critically summarizes the current knowledge about microRNAderegulation in prostate cancer disease, underlining present limits and future perspectives.",

author = "Valeria Coppola and {De Maria}, Ruggero and D{\'e}sir{\'e}e Bonci",

year = "2010",

month = mar,

doi = "10.1677/ERC-09-0172",

language = "English",

volume = "17",

journal = "Endocrine-Related Cancer",

issn = "1351-0088",

publisher = "BioScientifica Ltd.",

number = "1",

}

TY - JOUR

T1 - MicroRNAs and prostate cancer

AU - Coppola, Valeria

AU - De Maria, Ruggero

AU - Bonci, Désirée

PY - 2010/3

Y1 - 2010/3

N2 - Despite much progress in prostate cancer management, new diagnostic, prognostic and therapeutic tools are needed to predict disease severity, choose among the available treatments and establish more effective therapies for advanced prostate cancer. In the last few years, compelling evidence has documented the role of microRNAs as new broad-spectrum oncogenes or tumour suppressor genes, thus their use as diagnostic, prognostic and therapeutic biomolecules is envisaged. This review extensively and critically summarizes the current knowledge about microRNAderegulation in prostate cancer disease, underlining present limits and future perspectives.

AB - Despite much progress in prostate cancer management, new diagnostic, prognostic and therapeutic tools are needed to predict disease severity, choose among the available treatments and establish more effective therapies for advanced prostate cancer. In the last few years, compelling evidence has documented the role of microRNAs as new broad-spectrum oncogenes or tumour suppressor genes, thus their use as diagnostic, prognostic and therapeutic biomolecules is envisaged. This review extensively and critically summarizes the current knowledge about microRNAderegulation in prostate cancer disease, underlining present limits and future perspectives.

UR - http://www.scopus.com/inward/record.url?scp=77449157504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77449157504&partnerID=8YFLogxK

U2 - 10.1677/ERC-09-0172

DO - 10.1677/ERC-09-0172

M3 - Article

C2 - 19779034

AN - SCOPUS:77449157504

SN - 1351-0088

VL - 17

JO - Endocrine-Related Cancer

JF - Endocrine-Related Cancer

IS - 1

ER -

MicroRNAs and prostate cancer

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this